ArticleJMIR research protocols2026
Using Facebook to Improve Participation in Colorectal Cancer Screening: Protocol for a Cluster Randomized Controlled Trial.
Article in JMIR research protocols, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04296630 (Utilizing Social Media for Colorectal Cancer Screening), which is not on this map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Utilizing Social Media for Colorectal Cancer Screening: an Innovative Randomized Controlled Trial
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundColorectal cancer (CRC) screening participation in Canada is lower than the national target, and interventions designed to increase screening participation are generally expensive and have limited impact. Social media can be used as an innovative strategy to increase participation in cancer screening, particularly Facebook (FB), as it is the most popular social media platform for the population eligible for CRC screening.
objectiveThe aim of this study is to report on the protocol for a pragmatic cluster randomized controlled trial that will test the effectiveness of CRC social media advertisements on user engagement and screening intention.
methodsThe trial will target FB users aged 45 to 64 years who reside in the province of Ontario, Canada. There are 521 forward sortation areas (FSAs) in Ontario, and the randomization will be done at this level using the first 3 digits of the postal code. Rural and urban FSAs will be randomly allocated to one of the 6 study arms. In 4 arms, FB users will all receive one of 4 social media advertisements developed in previous studies, while in the fifth arm, a tailored strategy by sex will be tested. In the final arm, FB users will not be shown any advertisements. If users click on any of the advertisements, they will be directed to a webpage with more information on screening and a place to pledge their intention to screen for CRC. The study's primary outcome will be tested as a count measure, defined as the number of people per FSA who pledge their intention to screen for CRC. User engagement metrics, including impressions, link clicks, cost per link click, link click-through rate, and user comments, will be tracked across the 5 trial arms with advertisements shown.
resultsThis cluster randomized controlled trial will provide evidence on the use of FB as a tool for delivering CRC screening messages and influencing screening intentions. The comparison of message types within a fixed campaign budget could identify which approaches promote user engagement in both urban and rural populations.
conclusionsThis study has the potential to show that social media offers a cost-efficient, scalable approach to promote CRC screening. This approach is adaptable to other cancer screening programs and could provide evidence-based digital strategies for the promotion of cancer screening.
trial registrationClinicalTrials.gov NCT04296630; https://tinyurl.com/5y5k7yjb. INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID): DERR1-10.2196/86829.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.